Bernuau J, Rueff B, Benhamou JP: Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis. 1986, 6 (2): 97-106.
Article
CAS
PubMed
Google Scholar
Tanaka H, Uchida Y, Kaibori M, Hijikawa T, Ishizaki M, Yamada M, Matsui K, Ozaki T, Tokuhara K, Kamiyama Y, et al: Na+/H+ exchanger inhibitor, FR183998, has protective effect in lethal acute liver failure and prevents iNOS induction in rats. J Hepatol. 2008, 48 (2): 289-299.
Article
CAS
PubMed
Google Scholar
Itoh A, Isoda K, Kondoh M, Kawase M, Kobayashi M, Tamesada M, Yagi K: Hepatoprotective effect of syringic acid and vanillic acid on concanavalin a-induced liver injury. Biol Pharm Bull. 2009, 32 (7): 1215-1219.
Article
CAS
PubMed
Google Scholar
Girish C, Pradhan SC: Drug development for liver diseases: focus on picroliv, ellagic acid and curcumin. Fundam Clin Pharmacol. 2008, 22 (6): 623-632.
Article
CAS
PubMed
Google Scholar
Swem LR, Swem DL, O'Loughlin CT, Gatmaitan R, Zhao B, Ulrich SM, Bassler BL: A quorum-sensing antagonist targets both membrane-bound and cytoplasmic receptors and controls bacterial pathogenicity. Mol Cell. 2009, 35 (2): 143-153.
Article
CAS
PubMed
PubMed Central
Google Scholar
Limmer S, Haller S, Drenkard E, Lee J, Yu S, Kocks C, Ausubel FM, Ferrandon D: Pseudomonas aeruginosa RhlR is required to neutralize the cellular immune response in a Drosophila melanogaster oral infection model. Proc Natl Acad Sci U S A. 2011, 108 (42): 17378-17383.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hamamoto H, Tonoike A, Narushima K, Horie R, Sekimizu K: Silkworm as a model animal to evaluate drug candidate toxicity and metabolism. Comp Biochem Physiol C Toxicol Pharmacol. 2009, 149 (3): 334-339.
Article
PubMed
Google Scholar
Berger J: Alternative haematotoxicological testing. J Appl Biomed. 2010, 8: 19-22.
Article
CAS
Google Scholar
Hamamoto H, Kurokawa K, Kaito C, Kamura K, Manitra Razanajatovo I, Kusuhara H, Santa T, Sekimizu K: Quantitative evaluation of the therapeutic effects of antibiotics using silkworms infected with human pathogenic microorganisms. Antimicrob Agents Chemother. 2004, 48 (3): 774-779.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nagata M, Kaito C, Sekimizu K: Phosphodiesterase activity of CvfA is required for virulence in Staphylococcus aureus. J Biol Chem. 2008, 283 (4): 2176-2184.
Article
CAS
PubMed
Google Scholar
Hanada Y, Sekimizu K, Kaito C: Silkworm apolipophorin protein inhibits Staphylococcus aureus virulence. J Biol Chem. 2011, 286 (45): 39360-39369.
Article
CAS
PubMed
PubMed Central
Google Scholar
Asami Y, Horie R, Hamamoto H, Sekimizu K: Use of silkworms for identification of drug candidates having appropriate pharmacokinetics from plant sources. BMC Pharmacol. 2010, 10: 7-
Article
PubMed
PubMed Central
Google Scholar
Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S: The current state of serum biomarkers of hepatotoxicity. Toxicology. 2008, 245 (3): 194-205.
Article
CAS
PubMed
Google Scholar
Lindblom P, Rafter I, Copley C, Andersson U, Hedberg JJ, Berg AL, Samuelsson A, Hellmold H, Cotgreave I, Glinghammar B: Isoforms of alanine aminotransferases in human tissues and serum–differential tissue expression using novel antibodies. Arch Biochem Biophys. 2007, 466 (1): 66-77.
Article
CAS
PubMed
Google Scholar
Galicia-Moreno M, Rodriguez-Rivera A, Reyes-Gordillo K, Segovia J, Shibayama M, Tsutsumi V, Vergara P, Moreno MG, Muriel P: N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-beta and oxidative stress. Eur J Gastroenterol Hepatol. 2009, 21 (8): 908-914.
Article
CAS
PubMed
Google Scholar
Lee SS, Buters JT, Pineau T, Fernandez-Salguero P, Gonzalez FJ: Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem. 1996, 271 (20): 12063-12067.
Article
CAS
PubMed
Google Scholar
Doi H, Horie T: Salicylic acid-induced hepatotoxicity triggered by oxidative stress. Chem Biol Interact. 2010, 183 (3): 363-368.
Article
CAS
PubMed
Google Scholar
Damme B, Darmer D, Pankow D: Induction of hepatic cytochrome P4502E1 in rats by acetylsalicylic acid or sodium salicylate. Toxicology. 1996, 106 (1–3): 99-103.
Article
CAS
PubMed
Google Scholar
Ramm GA, Ruddell RG: Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Semin Liver Dis. 2005, 25 (4): 433-449.
Article
CAS
PubMed
Google Scholar
Fromenty B, Pessayre D: Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J Hepatol. 1997, 26 (Suppl 2): 43-53.
Article
CAS
PubMed
Google Scholar
Labbe G, Fromenty B, Freneaux E, Morzelle V, Letteron P, Berson A, Pessayre D: Effects of various tetracycline derivatives on in vitro and in vivo beta-oxidation of fatty acids, egress of triglycerides from the liver, accumulation of hepatic triglycerides, and mortality in mice. Biochem Pharmacol. 1991, 41 (4): 638-641.
Article
CAS
PubMed
Google Scholar
Fromenty B, Fisch C, Labbe G, Degott C, Deschamps D, Berson A, Letteron P, Pessayre D: Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther. 1990, 255 (3): 1371-1376.
CAS
PubMed
Google Scholar
Hubbard AK, Lohr CL, Hastings K, Clarke JB, Gandolfi AJ: Immunogenicity studies of a synthetic antigen of alpha methyl dopa. Immunopharmacol Immunotoxicol. 1993, 15 (5): 621-637.
Article
CAS
PubMed
Google Scholar
Chien RN, Yang LJ, Lin PY, Liaw YF: Hepatic injury during ketoconazole therapy in patients with onychomycosis: a controlled cohort study. Hepatology. 1997, 25 (1): 103-107.
Article
CAS
PubMed
Google Scholar
Berkovitch M, Pope E, Phillips J, Koren G: Pemoline-associated fulminant liver failure: testing the evidence for causation. Clin Pharmacol Ther. 1995, 57 (6): 696-698.
Article
CAS
PubMed
Google Scholar
Kawaguchi T, Harada M, Arimatsu H, Nagata S, Koga Y, Kuwahara R, Hisamochi A, Hino T, Taniguchi E, Kumemura H, et al: Severe hepatotoxicity associated with a N-nitrosofenfluramine-containing weight-loss supplement: report of three cases. J Gastroenterol Hepatol. 2004, 19 (3): 349-350.
Article
PubMed
Google Scholar
Shu L, Hollenberg PF: Identification of the cytochrome P450 isozymes involved in the metabolism of N-nitrosodipropyl-, N-nitrosodibutyl- and N-nitroso-n-butyl-n-propylamine. Carcinogenesis. 1996, 17 (4): 839-848.
Article
CAS
PubMed
Google Scholar
Nakagawa Y, Tayama S, Ogata A, Suzuki T, Ishii H: ATP-generating glycolytic substrates prevent N-nitrosofenfluramine-induced cytotoxicity in isolated rat hepatocytes. Chem Biol Interact. 2006, 164 (1–2): 93-101.
Article
CAS
PubMed
Google Scholar
Keppler DO, Rudigier JF, Bischoff E, Decker KF: The trapping of uridine phosphates by D-galactosamine. D-glucosamine, and 2-deoxy-D-galactose. A study on the mechanism of galactosamine hepatitis. Eur J Biochem. 1970, 17 (2): 246-253.
Article
CAS
PubMed
Google Scholar
Banno Y, Shimada T, Kajiura Z, Sezutsu H: The silkworm-an attractive BioResource supplied by Japan. Exp Anim. 2010, 59 (2): 139-146.
Article
CAS
PubMed
Google Scholar
Kaito C, Akimitsu N, Watanabe H, Sekimizu K: Silkworm larvae as an animal model of bacterial infection pathogenic to humans. Microb Pathog. 2002, 32 (4): 183-190.
Article
PubMed
Google Scholar
Kaito C, Kurokawa K, Matsumoto Y, Terao Y, Kawabata S, Hamada S, Sekimizu K: Silkworm pathogenic bacteria infection model for identification of novel virulence genes. Mol Microbiol. 2005, 56 (4): 934-944.
Article
CAS
PubMed
Google Scholar
Kaito C, Morishita D, Matsumoto Y, Kurokawa K, Sekimizu K: Novel DNA binding protein SarZ contributes to virulence in Staphylococcus aureus. Mol Microbiol. 2006, 62 (6): 1601-1617.
Article
CAS
PubMed
Google Scholar
Kaito C, Sekimizu K: A silkworm model of pathogenic bacterial infection. Drug Discov Ther. 2007, 1 (2): 89-93.
CAS
PubMed
Google Scholar
Matsumoto Y, Miyazaki S, Fukunaga DH, Shimizu K, Kawamoto S, Sekimizu K: Quantitative evaluation of cryptococcal pathogenesis and antifungal drugs using a silkworm infection model with Cryptococcus neoformans. J Appl Microbiol. 2012, 112 (1): 138-146.
Article
CAS
PubMed
Google Scholar
Matsumoto Y, Sumiya E, Sugita T, Sekimizu K: An invertebrate hyperglycemic model for the identification of anti-diabetic drugs. PLoS One. 2011, 6 (3): e18292-
Article
CAS
PubMed
PubMed Central
Google Scholar
Prescott LF, Park J, Ballantyne A, Adriaenssens P, Proudfoot AT: Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet. 1977, 2 (8035): 432-434.
Article
CAS
PubMed
Google Scholar
Butterworth BE, Smith-Oliver T, Earle L, Loury DJ, White RD, Doolittle DJ, Working PK, Cattley RC, Jirtle R, Michalopoulos G, et al: Use of primary cultures of human hepatocytes in toxicology studies. Cancer Res. 1989, 49 (5): 1075-1084.
CAS
PubMed
Google Scholar
Guillouzo A, Morel F, Langouet S, Maheo K, Rissel M: Use of hepatocyte cultures for the study of hepatotoxic compounds. J Hepatol. 1997, 26 (Suppl 2): 73-80.
Article
CAS
PubMed
Google Scholar
Yeon JH, Na D, Park JK: Hepatotoxicity assay using human hepatocytes trapped in microholes of a microfluidic device. Electrophoresis. 2010, 31 (18): 3167-3174.
Article
CAS
PubMed
Google Scholar
Martin R, Rose D, Yu K, Barros S: Toxicogenomics strategies for predicting drug toxicity. Pharmacogenomics. 2006, 7 (7): 1003-1016.
Article
CAS
PubMed
Google Scholar
Suzuki H, Inoue T, Matsushita T, Kobayashi K, Horii I, Hirabayashi Y: In vitro gene expression analysis of hepatotoxic drugs in rat primary hepatocytes. J Appl Toxicol. 2008, 28 (2): 227-236.
Article
CAS
PubMed
Google Scholar
Fan X, Lobenhofer EK, Chen M, Shi W, Huang J, Luo J, Zhang J, Walker SJ, Chu TM, Li L, et al: Consistency of predictive signature genes and classifiers generated using different microarray platforms. Pharmacogenomics J. 2010, 10 (4): 247-257.
Article
CAS
PubMed
PubMed Central
Google Scholar